AgingResearch.NewsJoin free

Waking salivary cortisol

Biomarker

1 paper1 finding

  • Human trial1

Interventions

1

Nicotinamide + d-ribose

downin humans1

1 study

  1. Nicotinamide + d-ribose decreases waking salivary cortisol in humans.

    “The waking salivary cortisol of the subjects steadily and significantly decreased (p = 0.026) in the RiaGev group in contrast to the placebo.”

    Human trialhealthy adults; compared with placebo1520 mg twice daily7 days

    A Combination of Nicotinamide and D-Ribose (RiaGev) Is Safe and Effective to Increase NAD⁺ Metabolome in Healthy Middle-Aged Adults: A Randomized, Triple-Blind, Placebo-Controlled, Cross-Over Pilot Clinical Trial

    Nutrients26 May 2022

More on Nicotinamide + d-ribose

Latest

Related